Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Undergraduate: Mobility, musculoskeletal health and arthritis - ICS

University of Ottawa

$4,950.00

The role of Sox7 during myogenesis in mouse embryonic stem cells

FY 2012-13

Summary
Treatments for patients with neuromuscular diseases, such as muscular dystrophy, have not been as easy to achieve as would be expected. Gene therapy approaches, while still promising, have had several setbacks. A method to repair and reverse muscle wasting would greatly enhance the outcome for these patients. Developing novel therapeutic methods will require enhancing our basic understanding of how skeletal muscle is made and repairs itself. The current proposal addresses the way that muscle is formed in mouse embryonic stem (ES) cells. ES cells are cells that are derived from an early embryo. These cells can divide to create more stem cells, termed proliferation, but can also differentiate into almost any other cell type. The major difficulty with using ES cells for cell therapy is that only a small population of ES cells can differentiate into skeletal muscle. Understanding how ES cells differentiate into skeletal muscle will provide insight into novel cell therapeutic approaches. We have shown that the protein Sox7 can increase the production of the Pax3 protein. This is important because Pax3 is found in muscle progenitor cells. These are stem cells that are able to proliferate and also to differentiate efficiently into skeletal muscle. We hypothesize that Sox7 can regulate the formation of muscle progenitor cells, since Sox7 could increase the amount of Pax3 in P19 cells. We will determine if the overexpression of Sox7 is able to increase the formation of skeletal muscle in mouse ES cells. We predict that Sox7 will be able to regulate the muscle progenitor gene, Pax3, during skeletal muscle development in ES cells and lead to enriched populations of ES-derived skeletal muscle. These studies will shed light on novel future approaches for cell therapy and will also provide an embryonic muscle population for future molecular and biochemical analysis.
Program
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
278103
Name
Laczko Dora
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Undergraduate: Mobility, musculoskeletal health & arthritis - IMHA
Projecttitle
The role of Sox7 during myogenesis in mouse embryonic stem cells
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$4,950
Cihrequipment2
$0
Programname2
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Keyworddelim
Myogenesis
Abstract
Treatments for patients with neuromuscular diseases, such as muscular dystrophy, have not been as easy to achieve as would be expected. Gene therapy approaches, while still promising, have had several setbacks. A method to repair and reverse muscle wasting would greatly enhance the outcome for these patients. Developing novel therapeutic methods will require enhancing our basic understanding of how skeletal muscle is made and repairs itself. The current proposal addresses the way that muscle is formed in mouse embryonic stem (ES) cells. ES cells are cells that are derived from an early embryo. These cells can divide to create more stem cells, termed proliferation, but can also differentiate into almost any other cell type. The major difficulty with using ES cells for cell therapy is that only a small population of ES cells can differentiate into skeletal muscle. Understanding how ES cells differentiate into skeletal muscle will provide insight into novel cell therapeutic approaches. We have shown that the protein Sox7 can increase the production of the Pax3 protein. This is important because Pax3 is found in muscle progenitor cells. These are stem cells that are able to proliferate and also to differentiate efficiently into skeletal muscle. We hypothesize that Sox7 can regulate the formation of muscle progenitor cells, since Sox7 could increase the amount of Pax3 in P19 cells. We will determine if the overexpression of Sox7 is able to increase the formation of skeletal muscle in mouse ES cells. We predict that Sox7 will be able to regulate the muscle progenitor gene, Pax3, during skeletal muscle development in ES cells and lead to enriched populations of ES-derived skeletal muscle. These studies will shed light on novel future approaches for cell therapy and will also provide an embryonic muscle population for future molecular and biochemical analysis.
Competitiondate
201301
Approvedterm2
0 yr 3 mths
Pinamesdelim
Laczko, Dora
Approvedterm
0 an 3 mois
Cihrcontribution2
~ $4,950~ $0~